183 related articles for article (PubMed ID: 37345432)
21. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging.
Zindy F; Quelle DE; Roussel MF; Sherr CJ
Oncogene; 1997 Jul; 15(2):203-11. PubMed ID: 9244355
[TBL] [Abstract][Full Text] [Related]
22. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
Phelps DE; Xiong Y
Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
[TBL] [Abstract][Full Text] [Related]
23. Reduced expression of cell cycle regulator p18(INK4C) in human hepatocellular carcinoma.
Morishita A; Masaki T; Yoshiji H; Nakai S; Ogi T; Miyauchi Y; Yoshida S; Funaki T; Uchida N; Kita Y; Funakoshi F; Usuki H; Okada S; Izuishi K; Watanabe S; Kurokohchi K; Kuriyama S
Hepatology; 2004 Sep; 40(3):677-86. PubMed ID: 15349907
[TBL] [Abstract][Full Text] [Related]
24. CtBP1 is expressed in melanoma and represses the transcription of p16INK4a and Brca1.
Deng H; Liu J; Deng Y; Han G; Shellman YG; Robinson SE; Tentler JJ; Robinson WA; Norris DA; Wang XJ; Zhang Q
J Invest Dermatol; 2013 May; 133(5):1294-301. PubMed ID: 23303449
[TBL] [Abstract][Full Text] [Related]
25. Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation.
Rodriguez-Puebla ML; Miliani de Marval PL; LaCava M; Moons DS; Kiyokawa H; Conti CJ
Am J Pathol; 2002 Aug; 161(2):405-11. PubMed ID: 12163365
[TBL] [Abstract][Full Text] [Related]
26. p16 loss rescues functional decline of Brca1-deficient mammary stem cells.
Scott A; Bai F; Chan HL; Liu S; Slingerland JM; Robbins DJ; Capobianco AJ; Pei XH
Cell Cycle; 2017 Apr; 16(8):759-764. PubMed ID: 28278054
[TBL] [Abstract][Full Text] [Related]
27. Genetic evidence for functional dependency of p18Ink4c on Cdk4.
Pei XH; Bai F; Tsutsui T; Kiyokawa H; Xiong Y
Mol Cell Biol; 2004 Aug; 24(15):6653-64. PubMed ID: 15254233
[TBL] [Abstract][Full Text] [Related]
28. Ara-c induces cell cycle G1/S arrest by inducing upregulation of the INK4 family gene or directly inhibiting the formation of the cell cycle-dependent complex CDK4/cyclin D1.
Sun F; Li N; Tong X; Zeng J; He S; Gai T; Bai Y; Liu L; Lu K; Shen J; Han M; Lu C; Dai F
Cell Cycle; 2019 Sep; 18(18):2293-2306. PubMed ID: 31322047
[TBL] [Abstract][Full Text] [Related]
29. A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice.
Vincent-Fabert C; Fiancette R; Rouaud P; Baudet C; Truffinet V; Magnone V; Guillaudeau A; Cogné M; Dubus P; Denizot Y
Am J Pathol; 2012 Apr; 180(4):1688-701. PubMed ID: 22326754
[TBL] [Abstract][Full Text] [Related]
30. Role of cdk4, p16INK4, and Rb expression in the prognosis of bronchioloalveolar carcinomas.
Ghazizadeh M; Jin E; Shimizu H; Fujiwara M; Arai S; Ohaki Y; Takemura T; Kawanami O
Respiration; 2005; 72(1):68-73. PubMed ID: 15753637
[TBL] [Abstract][Full Text] [Related]
31. Effects of exogenous p16INK4a on growth of cells with various status of cell-cycle regulators.
Suzuki-Takahashi I; Higashi H; Yoshida E; Nishimura S; Kitagawa M
Biochem Biophys Res Commun; 1997 May; 234(2):386-92. PubMed ID: 9177281
[TBL] [Abstract][Full Text] [Related]
32. The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy.
Wang Y; Wang Z; Qi Z; Yin S; Zhang N; Liu Y; Liu M; Meng J; Zang R; Zhang Z; Yang G
Mol Cancer; 2014 Apr; 13():94. PubMed ID: 24775809
[TBL] [Abstract][Full Text] [Related]
33. Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis.
Rodríguez-Díez E; Quereda V; Bellutti F; Prchal-Murphy M; Partida D; Eguren M; Kollmann K; Gómez de Cedrón M; Dubus P; Cañamero M; Martínez D; Sexl V; Malumbres M
Blood; 2014 Oct; 124(15):2380-90. PubMed ID: 25157181
[TBL] [Abstract][Full Text] [Related]
34. Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.
Nikitski AV; Rominski SL; Condello V; Kaya C; Wankhede M; Panebianco F; Yang H; Altschuler DL; Nikiforov YE
Thyroid; 2019 Oct; 29(10):1425-1437. PubMed ID: 31298630
[No Abstract] [Full Text] [Related]
35. The status of CDKN2A alpha (p16INK4A) and beta (p14ARF) transcripts in thyroid tumour progression.
Ferru A; Fromont G; Gibelin H; Guilhot J; Savagner F; Tourani JM; Kraimps JL; Larsen CJ; Karayan-Tapon L
Br J Cancer; 2006 Dec; 95(12):1670-7. PubMed ID: 17117177
[TBL] [Abstract][Full Text] [Related]
36. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development.
Zindy F; Soares H; Herzog KH; Morgan J; Sherr CJ; Roussel MF
Cell Growth Differ; 1997 Nov; 8(11):1139-50. PubMed ID: 9372237
[TBL] [Abstract][Full Text] [Related]
37. p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor.
Saab R; Rodriguez-Galindo C; Matmati K; Rehg JE; Baumer SH; Khoury JD; Billups C; Neale G; Helton KJ; Skapek SX
Cancer Res; 2009 Jan; 69(2):440-8. PubMed ID: 19147556
[TBL] [Abstract][Full Text] [Related]
38. p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-transduced primary mouse fibroblasts.
Carbone CJ; Graña X; Reddy EP; Haines DS
Cancer Res; 2007 May; 67(9):4130-7. PubMed ID: 17483323
[TBL] [Abstract][Full Text] [Related]
39. Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells.
Schwaller J; Pabst T; Koeffler HP; Niklaus G; Loetscher P; Fey MF; Tobler A
Leukemia; 1997 Jan; 11(1):54-63. PubMed ID: 9001419
[TBL] [Abstract][Full Text] [Related]
40. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
